Our preferred partner pharmacy offers individuals living in eligible states a cash-pay option of $149 per month for the 0.25mg dose and $299 per month for the 0.5, 1.0, 1.7, 2.0, and 2.4 mg doses
Patients should track their symptoms, including: Frequency and severity of gas Associated symptoms like sulfur burps Impact on daily activities Effectiveness of attempted remedies Special attention is needed for patients with: Kidney problems, as dehydration from digestive issues can worsen kidney function Diabetes, as digestive issues may affect blood sugar management Planned surgical procedures requiring anesthesia Patients experiencing persistent gas alongside acid reflux should note that about 2% of users report these combined symptoms, particularly at lower doses
GIP receptors are expressed in adipose tissue and play a direct role in fat storage and lipid metabolism
In a dedicated sleep apnea trial, tirzepatide reduced the apnea-hypopnea index (AHI) by 25.3 events per hour at 52 weeks compared to 5.3 with placebo
Tirzepatide was previously approved as Mounjaro to treat type 2 diabetes in the U.S